Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients.

Kuritzkes, D R

Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients. [electronic resource] - AIDS (London, England) Aug 1996 - 975-81 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0269-9370

10.1097/00002030-199610090-00007 doi


Adult
Anti-HIV Agents--pharmacology
Double-Blind Method
Drug Resistance
Drug Therapy, Combination
Female
Genes, Viral
HIV Infections--drug therapy
HIV-1--drug effects
Humans
Lamivudine--pharmacology
Male
Mutation--drug effects
Virus Replication
Zidovudine--pharmacology